A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in skin cancer and describes their different immunomodulatory roles in the tumor environment. The ...
Nov 19, 2024
0
25
Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on individuals diagnosed with viral ...
Nov 14, 2024
0
0
Head and neck squamous cell carcinoma (HNSCC) ranks as one of the most common cancers globally, with over 650,000 new cases reported each year. Surgical intervention is often the primary treatment, but surgeons face a difficult ...
Nov 7, 2024
0
0
A new study led by University of Cincinnati Cancer Center researchers details how the accumulation of copper helps clear cell renal cell carcinoma (ccRCC)—the most common kidney cancer—grow and advance in stage. The findings ...
Nov 7, 2024
0
9
A tightly tied waist cord of the underskirt (petticoat) traditionally worn under a saree, particularly in rural parts of India, may lead to what has been dubbed "petticoat cancer," warn doctors in the journal BMJ Case Reports ...
Nov 5, 2024
0
0
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a study in Frontiers of Medicine has identified a pivotal role for CD39 expression in modulating ...
Nov 5, 2024
0
0
Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma (HCC), and men are more likely to develop HCC than women. It typically develops ...
Nov 4, 2024
0
0
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers ...
Oct 25, 2024
0
32
Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also particularly challenging to treat. Physiologist Anna-Mart Engelbrecht, who heads the Cancer Research ...
Oct 22, 2024
0
0
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.
Oct 17, 2024
0
30
